Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FL019
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,241
Award facts
- Contract value 100% obligated
- $16,240.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $16,240.95 to supply Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 23, 2026. The place of performance is Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026, which serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. The company maintains significant contract relationships with the Defense Logistics Agency and Defense Health Agency, supplying a comprehensive portfolio of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Through its broader IDC with DLA, the company demonstrates capability to efficiently fulfill government contracts for essential pharmaceutical and medical commodities required by military treatment facilities and other federal medical institutions globally.
Quick answers
Who was awarded contract SPE2DR26FL019?
SPE2DR26FL019 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FL019 worth?
The government has obligated $16,241 on SPE2DR26FL019.
Is contract SPE2DR26FL019 an order under another contract?
Yes. SPE2DR26FL019 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FL019 competed?
The extent of competition for SPE2DR26FL019 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award